Pnc Financial Services Group, Inc. Acadia Pharmaceuticals Inc Transaction History

Pnc Financial Services Group, Inc.

$156 Billion
Q3 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 668 shares of ACAD stock, worth $11,469. This represents 0.0% of its overall portfolio holdings.

Number of Shares

668

Previous 823 18.83%

Holding current value

$11,469

Previous $13,000 23.08%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$15.14 - $19.14 $2,346 - $2,966	-155 Reduced 18.83%	668 $10,000
Q2 2024 Aug 09, 2024	BUY	$14.62 - $18.42 $248 - $313	17 Added 2.11%	823 $13,000
Q1 2024 May 10, 2024	BUY	$17.79 - $30.86 $3,255 - $5,647	183 Added 29.37%	806 $14,000
Q4 2023 Feb 09, 2024	SELL	$20.78 - $31.77 $1,101 - $1,683	-53 Reduced 7.84%	623 $19,000
Q3 2023 Nov 13, 2023	SELL	$20.84 - $33.47 $208 - $334	-10 Reduced 1.46%	676 $14,000
Q4 2022 Feb 10, 2023	BUY	$14.2 - $18.63 $7,100 - $9,315	500 Added 268.82%	686 $10,000
Q3 2022 Nov 10, 2022	BUY	$14.11 - $18.27 $860 - $1,114	61 Added 48.8%	186 $0
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $6,140 - $12,847	-472 Reduced 79.06%	125 $0
Q1 2022 May 12, 2022	SELL	$20.94 - $27.5 $30,530 - $40,095	-1,458 Reduced 70.95%	597 $0
Q4 2021 Feb 11, 2022	BUY	$16.79 - $27.09 $31,766 - $51,254	1,892 Added 1160.74%	2,055 $0
Q3 2021 Nov 05, 2021	BUY	$15.78 - $24.77 $173 - $272	11 Added 7.24%	163 $0
Q2 2021 Aug 06, 2021	SELL	$19.4 - $27.42 $1,765 - $2,495	-91 Reduced 37.45%	152 $0
Q1 2021 May 07, 2021	BUY	$25.02 - $54.99 $2,376 - $5,224	95 Added 64.19%	243 $0
Q4 2020 Feb 12, 2021	SELL	$41.04 - $56.79 $12,312 - $17,037	-300 Reduced 66.96%	148 $0
Q3 2020 Nov 06, 2020	SELL	$36.42 - $57.0 $257,890 - $403,617	-7,081 Reduced 94.05%	448 $0
Q2 2020 Aug 07, 2020	SELL	$39.26 - $52.73 $26,500 - $35,592	-675 Reduced 8.23%	7,529 $0
Q1 2020 May 08, 2020	BUY	$31.65 - $46.87 $175,214 - $259,472	5,536 Added 207.5%	8,204 $0
Q4 2019 Feb 07, 2020	SELL	$36.21 - $51.4 $5.15 Million - $7.31 Million	-142,177 Reduced 98.16%	2,668 $0
Q3 2019 Nov 08, 2019	SELL	$22.22 - $44.01 $953,926 - $1.89 Million	-42,931 Reduced 22.86%	144,845 $0
Q2 2019 Aug 09, 2019	SELL	$23.32 - $28.12 $2.84 Million - $3.43 Million	-121,934 Reduced 39.37%	187,776 $0
Q1 2019 May 10, 2019	SELL	$16.17 - $27.38 $1.39 Million - $2.35 Million	-85,964 Reduced 21.73%	309,710 $0
Q4 2018 Feb 08, 2019	BUY	$14.32 - $22.92 $5.66 Million - $9.06 Million	395,427 Added 160091.91%	395,674 $0
Q3 2018 Nov 09, 2018	SELL	$13.03 - $21.81 $2,241 - $3,751	-172 Reduced 41.05%	247 $0
Q2 2018 Aug 10, 2018	BUY	$15.07 - $22.34 $3,149 - $4,669	209 Added 99.52%	419 $0
Q1 2018 May 11, 2018	SELL	$22.47 - $32.33 $359 - $517	-16 Reduced 7.08%	210 $0
Q4 2017 Feb 09, 2018	SELL	$26.84 - $39.14 $3,757 - $5,479	-140 Reduced 38.25%	226 $0
Q3 2017 Nov 13, 2017	BUY	$29.49 - $38.37 $10,793 - $14,043	366	366 $0

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.78B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Acadia Pharmaceuticals Inc Transaction History